Skip to Content

M D12 (Doxazosin Mesylate 8 mg)

Pill with imprint M D12 is Purple, Round and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Mylan Pharmaceuticals Inc..

Doxazosin is used in the treatment of benign prostatic hyperplasia; raynaud's syndrome; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M D12

Doxazosin mesylate 8 mg M D12
Doxazosin mesylate 8 mg M D12 Front
Doxazosin mesylate 8 mg M D12 Back
Doxazosin mesylate 8 mg M D12
Doxazosin mesylate 8 mg M D12

Doxazosin Mesylate

Imprint
M D12
Strength
8 mg
Color
Purple
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, sodium starch glycolate type A potato, FD&C Blue No. 2, D&C Red No. 30

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-4028 Mylan Pharmaceuticals Inc.
67544-0273 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "M D12"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.